Literature DB >> 28447893

Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa.

Leticia Herminia Higa1, Horacio Emanuel Jerez1, Marcelo Alexandre de Farias2, Rodrigo Villares Portugal2, Eder Lilia Romero1, Maria Jose Morilla1.   

Abstract

AIM: Develop nanoparticulate agents for oral targeted delivery of dexamethasone (Dex) to macrophages of inflamed mucosa. MATERIALS &
METHODS: Solid archaeolipid nanoparticles (SAN-Dex) (compritol/Halorubrum tebenquichense polar archaeolipids/soybean phosphatidylcholine/Tween-80 4; 0.9; 0.3; 3% w/w) loaded with Dex were prepared. Their mucopenetration, stability under digestion and in vitro anti-inflammatory activity, were determined.
RESULTS: Ultra-small SAN-Dex strongly reduced the levels of TNF-α, IL-6 and IL-12 on J774A1 cells stimulated with lipopolysaccharides as compared with free Dex or loaded in ordinary solid lipid nanoparticles-Dex. After in vitro digestion, the anti-inflammatory activity of SAN-Dex was retained, while that of solid lipid nanoparticles-Dex was lost.
CONCLUSION: Because of their structural and pharmacodynamic features, SAN-Dex may be suitable for oral targeted delivery to inflamed mucosa.

Entities:  

Keywords:  digestion stability; inflammatory bowel disease; oral delivery

Mesh:

Substances:

Year:  2017        PMID: 28447893     DOI: 10.2217/nnm-2016-0437

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  5 in total

1.  Make It Simple: (SR-A1+TLR7) Macrophage Targeted NANOarchaeosomes.

Authors:  Federico Leonel Parra; Ayelen Tatiana Caimi; Maria Julia Altube; Diego Esteban Cargnelutti; Mónica Elba Vermeulen; Marcelo Alexandre de Farias; Rodrigo Villares Portugal; Maria Jose Morilla; Eder Lilia Romero
Journal:  Front Bioeng Biotechnol       Date:  2018-11-06

2.  Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture.

Authors:  Yossef Alnasser; Siva P Kambhampati; Elizabeth Nance; Labchan Rajbhandari; Shiva Shrestha; Arun Venkatesan; Rangaramanujam M Kannan; Sujatha Kannan
Journal:  Molecules       Date:  2018-04-27       Impact factor: 4.411

Review 3.  Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.

Authors:  Mingzhen Zhang; Didier Merlin
Journal:  Inflamm Bowel Dis       Date:  2018-06-08       Impact factor: 5.325

4.  The Anti-Inflammatory Effect of Nanoarchaeosomes on Human Endothelial Cells.

Authors:  Nancy Charó; Horacio Jerez; Silvio Tatti; Eder Lilia Romero; Mirta Schattner
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

Review 5.  New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy.

Authors:  Adrian H Teruel; Isabel Gonzalez-Alvarez; Marival Bermejo; Virginia Merino; Maria Dolores Marcos; Felix Sancenon; Marta Gonzalez-Alvarez; Ramon Martinez-Mañez
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.